NASDAQ:AVDR - Avedro Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$18.24 -0.40 (-2.15 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$18.64
Today's Range$18.05 - $19.49
52-Week Range$10.75 - $20.00
Volume45,440 shs
Average Volume122,205 shs
Market Capitalization$311.27 million
P/E RatioN/A
Dividend YieldN/A
Avedro, Inc., an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations. Its Avedro Corneal Remodeling platform treats corneal ectatic disorders and corrects refractive conditions; and KXL system in combination with Photrexa drug formulations used for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Avedro sells its products through a direct sales force in the United States and through medical device distributors internationally. The company was formerly known as ThermalVision, Inc. and changed its name to Avedro, Inc. in October 2005. Avedro, Inc. was incorporated in 2002 and is headquartered in Waltham, Massachusetts.

Receive AVDR News and Ratings via Email

Sign-up to receive the latest news and ratings for AVDR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Current SymbolNASDAQ:AVDR



Sales & Book Value

Annual Sales$27.67 million



Market Cap$311.27 million
Next Earnings Date8/8/2019 (Estimated)
OptionableNot Optionable

Avedro (NASDAQ:AVDR) Frequently Asked Questions

What is Avedro's stock symbol?

Avedro trades on the NASDAQ under the ticker symbol "AVDR."

How were Avedro's earnings last quarter?

Avedro Inc (NASDAQ:AVDR) announced its quarterly earnings data on Thursday, May, 9th. The company reported ($1.00) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($1.01) by $0.01. The business earned $8.77 million during the quarter, compared to analysts' expectations of $7.93 million. View Avedro's Earnings History.

When is Avedro's next earnings date?

Avedro is scheduled to release their next quarterly earnings announcement on Thursday, August 8th 2019. View Earnings Estimates for Avedro.

What price target have analysts set for AVDR?

6 Wall Street analysts have issued 1 year price objectives for Avedro's shares. Their predictions range from $16.00 to $21.00. On average, they expect Avedro's stock price to reach $19.40 in the next year. This suggests a possible upside of 6.4% from the stock's current price. View Analyst Price Targets for Avedro.

What is the consensus analysts' recommendation for Avedro?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avedro in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Avedro.

Has Avedro been receiving favorable news coverage?

Media stories about AVDR stock have been trending negative on Friday, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Avedro earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days.

Who are some of Avedro's key competitors?

What other stocks do shareholders of Avedro own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avedro investors own include NuVasive (NUVA), Cisco Systems (CSCO), Alector (ALEC), Harpoon Therapeutics (HARP), KLA-Tencor (KLAC), Marvell Technology Group (MRVL), Micron Technology (MU), Tcr2 Therapeutics (TCRR), Alibaba Group (BABA) and Dow Chemical (DOW).

Who are Avedro's key executives?

Avedro's management team includes the folowing people:
  • Dr. Reza Zadno, Pres, CEO & Director (Age 64)
  • Mr. Thomas E. Griffin, Chief Financial Officer (Age 56)
  • Dr. Rajesh K. Rajpal, Chief Medical Officer & Member of Advisory Board (Age 56)
  • Mr. James Schuermann, Chief Bus. Officer (Age 51)
  • Mr. Marc Friedman, Chief Scientific Officer

When did Avedro IPO?

(AVDR) raised $75 million in an initial public offering (IPO) on Thursday, February 14th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Cowen, Guggenheim Securities and SVB Leerink were co-managers.

When does the company's lock-up period expire?

Avedro's lock-up period expires on Tuesday, August 13th. Avedro had issued 5,000,000 shares in its public offering on February 14th. The total size of the offering was $70,000,000 based on an initial share price of $14.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Who are Avedro's major shareholders?

Avedro's stock is owned by many different of institutional and retail investors. Top institutional investors include Schonfeld Strategic Advisors LLC (0.81%), Redmile Group LLC (0.73%), JPMorgan Chase & Co. (0.71%), Lombard Odier Asset Management USA Corp (0.60%), Perceptive Advisors LLC (0.59%) and Perceptive Advisors LLC (0.59%). Company insiders that own Avedro stock include David First and Gilbert H Kliman. View Institutional Ownership Trends for Avedro.

Which major investors are buying Avedro stock?

AVDR stock was purchased by a variety of institutional investors in the last quarter, including Schonfeld Strategic Advisors LLC, Redmile Group LLC, JPMorgan Chase & Co., Lombard Odier Asset Management USA Corp, Perceptive Advisors LLC, Perceptive Advisors LLC, Laurion Capital Management LP and MYDA Advisors LLC. Company insiders that have bought Avedro stock in the last two years include David First and Gilbert H Kliman. View Insider Buying and Selling for Avedro.

How do I buy shares of Avedro?

Shares of AVDR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Avedro's stock price today?

One share of AVDR stock can currently be purchased for approximately $18.24.

How big of a company is Avedro?

Avedro has a market capitalization of $311.27 million and generates $27.67 million in revenue each year. Avedro employs 122 workers across the globe.

What is Avedro's official website?

The official website for Avedro is

How can I contact Avedro?

Avedro's mailing address is 201 JONES ROAD, WALTHAM MA, 02451. The company can be reached via phone at 781-768-3400 or via email at [email protected]

MarketBeat Community Rating for Avedro (NASDAQ AVDR)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  11 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  18
MarketBeat's community ratings are surveys of what our community members think about Avedro and other stocks. Vote "Outperform" if you believe AVDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVDR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/24/2019 by Staff

Featured Article: Current Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel